Description

Tacrolimus Capsules / Tablets

Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)

Exported by: Healthy Inc (Star Export House)

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. is a specialized Manufacturer of Tacrolimus Capsules and Tablets in India. Tacrolimus is a potent Immunosuppressant belonging to the calcineurin inhibitor class. It is a critical life-saving medication used for the prophylaxis of organ rejection in patients receiving allogenic liver, kidney, or heart transplants.

We offer Contract Manufacturing (Third Party) services for this Narrow Therapeutic Index (NTI) drug. Due to its high potency and specific bioavailability requirements, manufacturing requires high-precision equipment and containment strategies. Healthy Inc manages the export logistics, ensuring this temperature-sensitive critical care product reaches transplant centers and hospitals across the globe, including markets in Latin America, Southeast Asia, and Africa.

2. Product Specifications

3. Manufacturing Technology

Manufacturing NTI immunosuppressants requires advanced containment and formulation expertise.

• The Manufacturer: Healthy Life Pharma Pvt. Ltd.

  • Narrow Therapeutic Index (NTI): Tacrolimus has a very narrow margin between efficacy and toxicity. We use High-Shear Granulation and automated weight checking to ensure every single capsule/tablet falls within an extremely tight potency range (typically 95-105%). Small variances can lead to rejection (under-dosing) or toxicity (over-dosing).

  • Solubility Enhancement: Tacrolimus is poorly water-soluble. We employ Solid Dispersion Technology or specific micronization techniques to ensure consistent bioavailability.

  • Containment: As a potent drug, it is manufactured in Dedicated Areas with isolators to protect the product from cross-contamination and the operators from exposure.

• The Exporter: Healthy Inc

  • Protection: Tacrolimus is sensitive to moisture. We exclusively use Alu-Alu Cold Form Blisters with high-quality desiccants to ensure stability.

4. Quality Assurance

We adhere to strict Pharmacopoeial standards:

• Bioequivalence: For NTI drugs, our generic formulation is designed to be bioequivalent to the innovator (Prograf/Advagraf), ensuring transplant patients can switch safely.

• Dissolution: We test for precise release profiles. Immediate-release capsules must release rapidly, while prolonged-release tablets must follow a specific 24-hour curve.

• Impurities: We strictly monitor for degradation products (Tacrolimus tautomers) to ensure safety.

5. Why Use Tacrolimus?

It is the “Gold Standard” for transplant maintenance.

• Mechanism: It binds to a protein called FKBP-12. This complex inhibits Calcineurin, a phosphatase enzyme. This inhibition prevents the activation of T-lymphocytes (white blood cells), stopping the immune system from attacking the new organ.

• Key Indications:

  • Kidney Transplant: Prevention of rejection.

  • Liver Transplant: Prevention of rejection.

  • Heart Transplant: Prevention of rejection.

  • Refractory Rejection: Treatment of rejection episodes resistant to other drugs.

6. Export and Regulatory Support

We streamline the registration process for our B2B partners:

• Dossier Support: We offer CTD and ACTD Dossiers (with Bioequivalence studies where available) for registration.

• Certificates: Free Sale Certificate (FSC), COPP (WHO-GMP), and COA.

• Logistics: Efficient shipping via Air (Cold Chain/Temperature Controlled if required).

7. Frequently Asked Questions

• Q: Who manufactures Tacrolimus?

  A: Healthy Life Pharma Pvt. Ltd. manufactures it in India under strict NTI guidelines.

• Q: Is it the same as Cyclosporine?

  A: They are in the same class (calcineurin inhibitors), but Tacrolimus is significantly more potent (10-100 times) and often has a lower rate of acute rejection.

• Q: Why is the brand/generic consistency important?

  A: Because it is an NTI drug, patients should try to stay on the same manufacturer’s brand. If switching manufacturers, blood levels must be closely monitored.

CLINICAL PHARMACOLOGY & SAFETY INFORMATION

(For Registered Medical Practitioners & Patient Reference)

8. Dosage and Administration

• Standard Dosage: Highly individualized based on blood trough levels. Usually 0.10 – 0.30 mg/kg/day divided into two doses (every 12 hours) for immediate release.

• Monitoring: Therapeutic Drug Monitoring (TDM) of whole blood trough levels is mandatory.

• Administration: Take on an empty stomach (at least 1 hour before or 2 hours after a meal). Food reduces absorption by up to 37%.

9. Side Effects and Precautions

• Nephrotoxicity: Can cause kidney damage (dose-dependent).

• Neurotoxicity: Tremors, headache, insomnia, or seizures.

• Metabolic: New-onset diabetes after transplant (NODAT), hypertension, and hyperkalemia.

• Interactions: Metabolized by CYP3A4. Avoid Grapefruit juice, Ketoconazole, Erythromycin, and Rifampicin, as they drastically alter Tacrolimus levels.

10. Storage Instructions

• Store below 25°C in a dry place.

• Protect from moisture. Use immediately after opening the foil.